Skip to content
City PM
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • DE
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • DE
Sunday 17 December 2017 2:26 pm

UK mattress startup Simba Sleep raises £40m and is heading for profit in some markets

By: Lynsey Barber

Add as a preferred source on Google

Simba Sleep, one of several startups hoping to disrupt the world of sleep, has bedded fresh cash to fuel global expansion as it nears profitability in some markets.

The £40m series B round of investment comes from previous backers Nigel Wray, a City heavywight and chairman of Saracens rugby club, Wharton Asset Management and Swiss bank Lombard Odier and was led by new backer Atami Capital.

Read more: This startup using AI to help hotels boost revenues has raised £2.5m

Simba is targeting revenue to grow by a sixth in the next two years – from £41m forecast for 2017 to £267m by the end of 2019 – and said it is moving towards profitability in the UK and France, two of its 35 markets.

The capital injection takes total funding of the two-year-old startup to £58.5m, with Citi banker Michel de Carvalho, advertising top dog Sir John Hegarty, serial startup investor Tom Teichman and Innocent Drinks founder Richard Reed among its investors.

“This fourth-round investment ensures innovation remains at the core of our business ethos and aligns with our global momentum," said chief executive and co-founder James Cox.

"By the end of 2017, we will have presence in over twenty global retail outlets and will have achieved 350 per cent year-on-year revenue growth. We’re also on course for profitability in our core markets in early 2018 as well as exponential growth in the large £10bn US and £11bn Asian markets.”

Read more: European fintech startup iZettle has raised €40m ahead of a potential IPO

Wray, a backer of Domino's Pizza, fintech Nutmeg and wine company Chapel Down among others, said he had "honestly never seen sales growth like this".

Simba has heralded its innovative technology and many patents, however, it was censured by the UK advertising regulator for claiming the "most advanced" mattress in the world.

Simba faces competition from UK-listed Eve and US firms Leesa and Casper.

 

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Tech

Trending Articles

  • I’ve taken the best train trips in the world. Here are my 5 favourites

  • Nothing fails to file accounts months after dissolution threat

  • Nottingham Forest owner Marinakis announces £210m stadium plans

  • Harry Styles at Wembley Stadium review: running through the grief

  • Burnham tax plans spark investor rush to bank capital gains

More from City PM

  • HUI (HUI:VSE) Merges Traditional and Crypto Finance: Commences Continuous Trading in Vienna With Leading Market Maker and Announces Impending Token Listing on Major Global Exchange

    Business Wire
  • Everton ‘surprised and angered’ at losing £40m legal case with Burnley

    Sport Business
    GettyImages 2272351712 showing a business meeting with diverse professionals discussing strategies around a conference table
  • Concern as gambling black market set for £40m Royal Ascot boost

    Sport Business
    GettyImages 2282074836 showing a significant event with key figures in a professional setting, highlighting a major develo...
  • LivaNova Demonstrates 84.5% Cumulative Response Rate with PolySync Programming in OSPREY Study for Obstructive Sleep Apnea

    Business Wire
  • Alkermes Announces Orphan Drug Designations for Alixorexton in the U.S. and Europe

    Business Wire
  • ‘It’s gone’: How a social housing scheme left amateur investors £40m out of pocket

    Property
    The Renter's Rights Bill was debated in the House of Commons on Monday
  • Nscale and ElevenLabs power £41bn AI boom as Britain cements unicorn crown

    Tech
    Canada skyline featuring iconic skyscrapers and modern architecture against a clear blue sky
  • Alkermes to Present New Data on Alixorexton and LUMRYZ® (sodium oxybate) at SLEEP 2026, Highlighting Breadth of Sleep Medicine Research

    Business Wire

City PM — European politics, business and analysis.

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Topics

  • Business
  • Markets
  • AI
  • Technology
  • Opinion
  • Energy

More

  • Politics
  • Economics
  • Fintech
  • Legal
  • Sport
  • Life

Company

  • About City PM
  • Editorial Policy
  • Corrections
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 City PM · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
About · Editorial Policy · Corrections · Contact · Privacy